Mandating Drug Price Transparency (Part II)
Drug prices have captured political leaders’ attention. See, e.g., Robert Pear, Big Pharma’s Nightmare: Trump Crossing the Aisle to Curb Drug Prices, N.Y.TIMES A23 (Oct. 21, 2018); Robert Langreth, Quicktake: Drug Prices, BLOOMBERG (Jan. 25, 2016)(updated May 11, 2018). On October 11, 2018, the Centers for Medicare and Medicaid Services (“CMS”) took a modest step […]